Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
Category: Media
Researchers Gave People Synthetic Pot. Here’s What Happened.
New study from our group assessed cognitive and subjective effects of a synthetic cannabinoid, JWH-018. Read coverage of the publication from Live Science.
Esketamine als antidepressivum – Jan Ramaekers
07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast here (scroll to 1 hr 51 min)
The Ethical and Ecological Considerations of Inhaling Bufotoxins from Incilius Alvarius – Malin Uthaug
Malin Uthaug, PhD student in our department, recently discussed the ethical considerations of inhaling bufotoxins from Incilius Alvarius. Read her opinions on this practice here
Wim Riedel: link between university and industry
On 15 February Wim will bid farewell to his career at Maastricht University. Prof. Wim Riedel: Drummer, cyclist, pilot and Professor of Experimental Psychopharmacology at the Faculty of Psychology and Neuroscience (FPN). Read more about Wim's career and contribution to psychopharmacology here.
